0.00Open0.01Pre Close0 Volume146 Open Interest807.50Strike Price0.00Turnover1102.73%IV5.54%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0166Delta0.0035Gamma76510.00Leverage Ratio-324.7598Theta0.0000Rho1271.49Eff Leverage0.0004Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet